Multiple Neuroinvasive Pathways in COVID-19

[1]  W. Lukiw,et al.  SARS-CoV-2 Infectivity and Neurological Targets in the Brain , 2020, Cellular and Molecular Neurobiology.

[2]  H. Krumholz,et al.  Extrapulmonary manifestations of COVID-19 , 2020, Nature Medicine.

[3]  D. Thacker.  Multisystem Inflammatory Syndrome in Children (MIS-C): , 2020, Delaware journal of public health.

[4]  V. Navarro,et al.  Orbitofrontal involvement in a neuroCOVID‐19 patient , 2020, Epilepsia.

[5]  M. Mckee,et al.  COVID-19: a complex multisystem disorder , 2020, British Journal of Anaesthesia.

[6]  Imen Megdiche,et al.  Brain MRI Findings in Severe COVID-19: A Retrospective Observational Study , 2020, Radiology.

[7]  Pardis C Sabeti,et al.  Neuropathological Features of Covid-19 , 2020, The New England journal of medicine.

[8]  A. Harky,et al.  Neurological Manifestations of COVID‐19: A systematic review and current update , 2020, Acta neurologica Scandinavica.

[9]  L. Politi,et al.  Magnetic Resonance Imaging Alteration of the Brain in a Patient With Coronavirus Disease 2019 (COVID-19) and Anosmia. , 2020, JAMA neurology.

[10]  T. Segura,et al.  Neurologic manifestations in hospitalized patients with COVID-19 , 2020, Neurology.

[11]  J. Lechien,et al.  Loss of Smell and Taste in 2013 European Patients With Mild to Moderate COVID-19 , 2020, Annals of Internal Medicine.

[12]  H. Bolay,et al.  COVID‐19 is a Real Headache! , 2020, Headache.

[13]  A. Harky,et al.  Neurological Manifestations of COVID-19: A review. , 2020, Acta neurologica Scandinavica.

[14]  D. Lutchman,et al.  COVID-19 and vaping: risk for increased susceptibility to SARS-CoV-2 infection? , 2020, European Respiratory Journal.

[15]  Duzgun Yildirim,et al.  Brain MRI Findings in Patients in the Intensive Care Unit with COVID-19 Infection , 2020, Radiology.

[16]  M. T. Medina,et al.  The neurology of COVID-19 revisited: A proposal from the Environmental Neurology Specialty Group of the World Federation of Neurology to implement international neurological registries , 2020, Journal of the Neurological Sciences.

[17]  Fang Li,et al.  Cell entry mechanisms of SARS-CoV-2 , 2020, Proceedings of the National Academy of Sciences.

[18]  T. Dick,et al.  Brainstem inflammation modulates the ventilatory pattern and its variability after acute lung injury in rodents , 2020, The Journal of physiology.

[19]  N. Xiong,et al.  Emerging Evidence for Neuropsycho-Consequences of COVID-19 , 2020, Current neuropharmacology.

[20]  G. Shukla,et al.  COVID-19, SARS and MERS: A neurological perspective , 2020, Journal of Clinical Neuroscience.

[21]  Marco Maria Fontanella,et al.  SARS-CoV-2 can induce brain and spine demyelinating lesions , 2020, Acta Neurochirurgica.

[22]  R. Henry.  Etymologia: Coronavirus , 2020, Emerging Infectious Diseases.

[23]  S. Farmer,et al.  Characteristics of ischaemic stroke associated with COVID-19 , 2020, Journal of Neurology, Neurosurgery, and Psychiatry.

[24]  Amit Kumar Srivastava,et al.  Is the Collapse of the Respiratory Center in the Brain Responsible for Respiratory Breakdown in COVID-19 Patients? , 2020, ACS chemical neuroscience.

[25]  I. Appollonio,et al.  Guillain-Barré syndrome related to COVID-19 infection , 2020, Neurology: Neuroimmunology & Neuroinflammation.

[26]  Thomas J Oxley,et al.  Large-Vessel Stroke as a Presenting Feature of Covid-19 in the Young , 2020, The New England journal of medicine.

[27]  E. Ely,et al.  COVID-19: ICU delirium management during SARS-CoV-2 pandemic , 2020, Critical Care.

[28]  B. Tran,et al.  Do psychiatric patients experience more psychiatric symptoms during COVID-19 pandemic and lockdown? A case-control study with service and research implications for immunopsychiatry , 2020, Brain, Behavior, and Immunity.

[29]  G. Santis.  SARS-CoV-2: A new virus but a familiar inflammation brain pattern , 2020, Brain, Behavior, and Immunity.

[30]  P. Calabresi,et al.  Does SARS‐Cov‐2 invade the brain? Translational lessons from animal models , 2020, European journal of neurology.

[31]  Nils Kucher,et al.  Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy , 2020, Thrombosis Research.

[32]  Vikram Thakur,et al.  COVID 2019-suicides: A global psychological pandemic , 2020, Brain, Behavior, and Immunity.

[33]  Surajit Ghosh,et al.  Neurological Insights of COVID-19 Pandemic , 2020, ACS chemical neuroscience.

[34]  N. Kuroda.  Epilepsy and COVID-19: Associations and important considerations , 2020, Epilepsy & Behavior.

[35]  M. Fowkes,et al.  Central nervous system involvement by severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) , 2020, Journal of medical virology.

[36]  H. Ulrich,et al.  CD147 as a Target for COVID-19 Treatment: Suggested Effects of Azithromycin and Stem Cell Engagement , 2020, Stem Cell Reviews and Reports.

[37]  G. Sani,et al.  Affective temperament, attachment style, and the psychological impact of the COVID-19 outbreak: an early report on the Italian general population , 2020, Brain, Behavior, and Immunity.

[38]  T. Jiang,et al.  The differential psychological distress of populations affected by the COVID-19 pandemic , 2020, Brain, Behavior, and Immunity.

[39]  S. Kremer,et al.  Neurologic Features in Severe SARS-CoV-2 Infection , 2020, The New England journal of medicine.

[40]  A. Kriško,et al.  SARS‐CoV‐2: At the Crossroad Between Aging and Neurodegeneration , 2020, Movement disorders : official journal of the Movement Disorder Society.

[41]  J. Kohn,et al.  Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19? Neuropsychiatric symptoms and potential immunologic mechanisms , 2020, Brain, Behavior, and Immunity.

[42]  R. Butowt,et al.  SARS-CoV-2: Olfaction, Brain Infection, and the Urgent Need for Clinical Samples Allowing Earlier Virus Detection , 2020, ACS chemical neuroscience.

[43]  D. Gommers,et al.  Incidence of thrombotic complications in critically ill ICU patients with COVID-19 , 2020, Thrombosis Research.

[44]  T. Lv,et al.  Encephalitis as a clinical manifestation of COVID-19 , 2020, Brain, Behavior, and Immunity.

[45]  L. Mao,et al.  Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China. , 2020, JAMA neurology.

[46]  Robert Simpson,et al.  Rehabilitation After Critical Illness in People With COVID-19 Infection , 2020, American journal of physical medicine & rehabilitation.

[47]  S. Maskatia,et al.  COVID-19 and Kawasaki Disease: Novel Virus and Novel Case. , 2020, Hospital pediatrics.

[48]  R. Carlier,et al.  Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study , 2020, European Archives of Oto-Rhino-Laryngology.

[49]  N. Enomoto,et al.  A first case of meningitis/encephalitis associated with SARS-Coronavirus-2 , 2020, International Journal of Infectious Diseases.

[50]  Dingding Shen,et al.  Guillain-Barré syndrome associated with SARS-CoV-2 infection: causality or coincidence? , 2020, The Lancet Neurology.

[51]  N. Kabbani,et al.  Does COVID19 Infect the Brain? If So, Smokers Might Be at a Higher Risk , 2020, Molecular Pharmacology.

[52]  J. Talan.  Neurologists in Italy to Colleagues in US: Look for Poorly-Defined Neurologic Conditions in Patients with COVID-19 , 2020 .

[53]  Suresh Patel,et al.  COVID-19–associated Acute Hemorrhagic Necrotizing Encephalopathy: CT and MRI Features , 2020, Radiology.

[54]  N. Karimi,et al.  Frequent Convulsive Seizures in an Adult Patient with COVID-19: A Case Report , 2020, Iranian Red Crescent Medical Journal.

[55]  K. Shi,et al.  Structural basis of receptor recognition by SARS-CoV-2 , 2020, Nature.

[56]  D. Wang,et al.  The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status , 2020, Military Medical Research.

[57]  Usman Ali,et al.  Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host–Virus Interaction, and Proposed Neurotropic Mechanisms , 2020, ACS chemical neuroscience.

[58]  Yuyi Wang,et al.  Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID‐19) implicate special control measures , 2020, Journal of medical virology.

[59]  Qiang Zhou,et al.  Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2 , 2020, Science.

[60]  K. Hashimoto,et al.  Vicarious traumatization in the general public, members, and non-members of medical teams aiding in COVID-19 control , 2020, Brain, Behavior, and Immunity.

[61]  Y. Xian,et al.  Acute cerebrovascular disease following COVID-19: a single center, retrospective, observational study , 2020, Stroke and vascular neurology.

[62]  J. Lee,et al.  Posttraumatic stress disorder and depression of survivors 12 months after the outbreak of Middle East respiratory syndrome in South Korea , 2020, BMC Public Health.

[63]  Shao-hua Hu,et al.  Factors Associated With Mental Health Outcomes Among Health Care Workers Exposed to Coronavirus Disease 2019 , 2020, JAMA network open.

[64]  K. Stein,et al.  Potential neurological symptoms of COVID-19 , 2020, Therapeutic advances in neurological disorders.

[65]  Tsutomu Hashikawa,et al.  The neuroinvasive potential of SARS‐CoV2 may play a role in the respiratory failure of COVID‐19 patients , 2020, Journal of medical virology.

[66]  Jiyuan Zhang,et al.  Pathological findings of COVID-19 associated with acute respiratory distress syndrome , 2020, The Lancet Respiratory Medicine.

[67]  Alain Le Coupanec,et al.  Human Coronaviruses and Other Respiratory Viruses: Underestimated Opportunistic Pathogens of the Central Nervous System? , 2019, Viruses.

[68]  E. Ely,et al.  Long-term cognitive impairment after acute respiratory distress syndrome: a review of clinical impact and pathophysiological mechanisms , 2019, Critical Care.

[69]  Sube Banerjee,et al.  Assessment and Management of HIV-Associated Cognitive Impairment: Experience from a Multidisciplinary Memory Service for People Living with HIV , 2019, Brain sciences.

[70]  C. Bell,et al.  Psychological distress and psychiatric disorder after natural disasters: systematic review and meta-analysis. , 2018, The British journal of psychiatry : the journal of mental science.

[71]  J. Rini,et al.  Axonal Transport Enables Neuron-to-Neuron Propagation of Human Coronavirus OC43 , 2018, Journal of Virology.

[72]  Fu-Huang Lin,et al.  Anti-herpetic Medications and Reduced Risk of Dementia in Patients with Herpes Simplex Virus Infections—a Nationwide, Population-Based Cohort Study in Taiwan , 2018, Neurotherapeutics.

[73]  Massimo Filippi,et al.  Cognition in multiple sclerosis , 2018, Neurology.

[74]  Zhiqi Zeng,et al.  Epidemiology and clinical characteristics of human coronaviruses OC43, 229E, NL63, and HKU1: a study of hospitalized children with acute respiratory tract infection in Guangzhou, China , 2017, European Journal of Clinical Microbiology & Infectious Diseases.

[75]  J. Heo,et al.  Neurological Complications during Treatment of Middle East Respiratory Syndrome , 2017, Journal of clinical neurology.

[76]  X. Li,et al.  Coronavirus Infections in the Central Nervous System and Respiratory Tract Show Distinct Features in Hospitalized Children , 2017, Intervirology.

[77]  T. Jacques,et al.  Human Coronavirus OC43 Associated with Fatal Encephalitis. , 2016, The New England journal of medicine.

[78]  M. Raizada,et al.  Increasing brain angiotensin converting enzyme 2 activity decreases anxiety-like behavior in male mice by activating central Mas receptors , 2016, Neuropharmacology.

[79]  M. Koubeissi,et al.  The piriform, perirhinal, and entorhinal cortex in seizure generation , 2015, Front. Neural Circuits.

[80]  A. Hajeer,et al.  Severe neurologic syndrome associated with Middle East respiratory syndrome corona virus (MERS-CoV) , 2015, Infection.

[81]  Z. Memish,et al.  Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia , 2014, International Journal of Infectious Diseases.

[82]  M. Simu,et al.  HIV-associated Neurocognitive Disorders: A Historical Review , 2012, The neurologist.

[83]  D. Needham,et al.  Improving long-term outcomes after discharge from intensive care unit: Report from a stakeholders' conference* , 2012, Critical care medicine.

[84]  M. A. Khan,et al.  Frequency of hypoxic events in patients on a mechanical ventilator , 2011, International journal of critical illness and injury science.

[85]  E. Lazartigues,et al.  Angiotensin‐converting enzyme 2 in the brain: properties and future directions , 2008, Journal of neurochemistry.

[86]  David K. Meyerholz,et al.  Severe Acute Respiratory Syndrome Coronavirus Infection Causes Neuronal Death in the Absence of Encephalitis in Mice Transgenic for Human ACE2 , 2008, Journal of Virology.

[87]  R. Whitley.  Herpes simplex encephalitis: adolescents and adults. , 2006, Antiviral research.

[88]  L. Tsai,et al.  Neurological manifestations in severe acute respiratory syndrome. , 2005, Acta neurologica Taiwanica.

[89]  Bo Zhang,et al.  Multiple organ infection and the pathogenesis of SARS , 2005, The Journal of experimental medicine.

[90]  E. Shapiro,et al.  Association between a Novel Human Coronavirus and Kawasaki Disease , 2005, The Journal of infectious diseases.

[91]  L. Tsai,et al.  Neuromuscular disorders in severe acute respiratory syndrome. , 2004, Archives of neurology.

[92]  J. Fleming,et al.  Cerebrospinal fluid antibodies to coronavirus in patients with Parkinson's disease , 2004, Movement disorders : official journal of the Movement Disorder Society.

[93]  J. Sung,et al.  Detection of SARS Coronavirus RNA in the Cerebrospinal Fluid of a Patient with Severe Acute Respiratory Syndrome , 2003, Clinical chemistry.

[94]  O. Eeg‐Olofsson.  Virological and immunological aspects of seizure disorders , 2003, Brain and Development.

[95]  T. Jernigan,et al.  Elevated cerebrospinal fluid quinolinic acid levels are associated with region-specific cerebral volume loss in HIV infection. , 2001, Brain : a journal of neurology.

[96]  M. Reunanen,et al.  Antibodies to coronaviruses OC43 and 229E in multiple sclerosis patients , 1982, Neurology.

[97]  M. Petrič,et al.  HERPES-SIMPLEX VIRAL GENOME AND SENILE AND PRESENILE DEMENTIAS OF ALZHEIMER AND PICK , 1980, The Lancet.

[98]  W. Scoville,et al.  LOSS OF RECENT MEMORY AFTER BILATERAL HIPPOCAMPAL LESIONS , 1957, Journal of neurology, neurosurgery, and psychiatry.

[99]  D. Arciniegas,et al.  Cognitive sequelae of hypoxic-ischemic brain injury: a review. , 2010, NeuroRehabilitation.

[100]  D. Shprecher,et al.  The syndrome of delayed post-hypoxic leukoencephalopathy. , 2010, NeuroRehabilitation.

[101]  H. Faden,et al.  Detection of coronavirus in the central nervous system of a child with acute disseminated encephalomyelitis. , 2004, Pediatrics.

[102]  Lewis B. Haberly,et al.  Comparative Aspects of Olfactory Cortex , 1990 .

[103]  Stephen M. Rao,et al.  Cognition in multiple sclerosis State of the fi eld and priorities for the future , 2022 .